Advertisement

Burden of Disease Attributable to Obesity and Overweight: Korean Focus

  • Seok-Jun Yoon
  • Jae-Hyun Park
Reference work entry

Abstract:

This chapter estimates the burden of disease attributable to  overweight and  obesity in Korea using disability adjusted life-years (DALYs). First, overweight- and obesity-related diseases and their  relative risks (RRs) were selected by systematic review. Second, population-attributable fractions (PAFs) were computed by using a formula that included RR and the prevalence of exposure (Pe) of overweight and obesity. Third, the DALYs of overweight and obesity-related diseases in Korea were estimated. Finally, the attributable burden (AB) of disease due to overweight and obesity was calculated as the sum of the products resulting from the multiplication of the DALYs of overweight and obesity-related diseases by their PAFs.

In 2002, the disease burden attributable to overweight was 827.1 PYs overall: 732.6 for men and 922.9 for women per 100,000 persons. The disease burden attributable to obesity was 260.0 PYs overall: 144.2 for men and 377.3 for women. The burden of diabetes attributable to overweight and obesity was higher than that of any other disease in both genders. The disease burden attributable to overweight was 3.2 times higher than that attributable to obesity. In conclusion, the greatest disease burden attributable to a high BMI occurred among those with only moderately elevated BMI scores, such as overweight, and not those with extremely elevated BMI scores, such as obesity. This suggests that population-based, public health intervention is more effective than high-risk group-focused strategies at reducing the burden of disease attributable to overweight and obesity in Korea.

Keywords

Ischemic Heart Disease Disease Burden Relative Risk Ratio Population Attributable Fraction Socioeconomic Burden 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations:

AB

attributable burden

AICR

American Institute For Cancer Research

BMI

 body mass index

DALY

disability adjusted life-year

GBD

 global burden of disease

PAFs

population attributable fractions

Pe

prevalence of exposure

PYs

person-years

RR

relative risk

WHO

World Health Organization

YLL

years of life lost due to premature death

YLD

 years lived with disability

References

  1. American Institute for Cancer Research. (1997). Food, Nutrition and the Prevention of Cancer: A Global Perspective. American Institute for Cancer Research, Washington DC.Google Scholar
  2. Bray GA. (2003a). Endocrinol Metab Clin North Am. 32(4): 787–804.PubMedCrossRefGoogle Scholar
  3. Bray GA. (2003b). Risks of obesity. Prim Care. 30(2): 281–299.Google Scholar
  4. British Nutrition Foundation Task Force. (1999). Obesity. UK Blackwell, Oxford.Google Scholar
  5. Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, Speizer FE, Manson JE. (1997). Am J Epidemiol. 145(7): 614–619.PubMedGoogle Scholar
  6. Center for Evidence Based Medicine (CEBM). (2003). Levels of Evidence and Grades of Recommendation. Available http://www.cebm.net/levels of evidence.asp (2003.11).
  7. Cedergren MI. (2004). Obstet Gynecol. 103(2): 219–224.PubMedCrossRefGoogle Scholar
  8. Colditz GA, Willett WC, Rotnitzky A, Manson JE. (1995). Ann Intern Med. 122(7): 481–486.PubMedGoogle Scholar
  9. Colditz GA, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, Arky RA, Speizer FE. (1990). Am J Epidemiol. 132(3): 501–513.PubMedGoogle Scholar
  10. Cook NR, Cohen J, Hebert P, Taylor JO, Hennekens CH. (1995). Arch Intern Med. 155: 701–709.PubMedCrossRefGoogle Scholar
  11. Deurenberg P, Deurenberg-Yap M, Foo LF, Schmidt G, Wang J. (2003). Eur J Clin Nutr. 57: 405–409.PubMedCrossRefGoogle Scholar
  12. Deurenberg-Yap M, Schmidt G, van Staveren WA, Deurenberg P. (2000). Int J Obes Relat Metab Disord. 24: 1011–1017.PubMedCrossRefGoogle Scholar
  13. Deurenberg-Yap M, Chew SK, Deurenberg P. (2002). Obes Rev. 3: 209–215.PubMedCrossRefGoogle Scholar
  14. Deurenberg-Yap M, Chew SK, Lin VF, Tan BY, van Staveren WA, Deurenberg P. (2001). Int J Obes Relat Metab Disord. 25: 1554–1562.PubMedCrossRefGoogle Scholar
  15. Dudeja V, Misra A, Pandey RM, Devina G, Kumar G, Vikram NK. (2001). Br J Nutr. 86: 105–112.PubMedCrossRefGoogle Scholar
  16. Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman B, Aliabadi P, Levy D. (1997). Arthritis Rheum. 40(4): 728–733.PubMedCrossRefGoogle Scholar
  17. Furberg AS, Thune I. (2003). Int J Cancer. 104(6): 669–676.PubMedCrossRefGoogle Scholar
  18. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. (2001). Arch Intern Med. 161(7): 996–1002.PubMedCrossRefGoogle Scholar
  19. Jee SH, Pastor-Barriuso R, Appel LJ, Suh I, Miller ER 3rd, Guallar E. (2005). Am J Epidemiol. 162(1): 42–48.PubMedCrossRefGoogle Scholar
  20. Jeong BG, Moon OR, Kim NS, Kang JH, Yoon TH, Lee SY, Lee SJ. (2002). Kor J Prev Med. 35(1): 1–12 (Korean).CrossRefGoogle Scholar
  21. Kashyap S, Moher D, Fung MF, Rosenwaks Z. (2004). Obstet Gynecol. 103(4): 785–794.PubMedCrossRefGoogle Scholar
  22. Kato I, Nomura A, Stemmermann GN, Chyou PH. (1992). Dig Dis Sci. 37(5): 784–790.PubMedCrossRefGoogle Scholar
  23. Kim NS, Moon OR, Kang JH, Lee SY, Jeong BG, Lee SJ, Yoon TH, Hwang KH. (2001). Kor J Prev Med. 34(4): 309–315 (Korean).Google Scholar
  24. Layde PM, Vessey MP, Yeates D. (1982). J Epidemiol Community Health. 36(4): 274–278.PubMedCrossRefGoogle Scholar
  25. Lee HK, Yoon SJ, Do YK, Kwon YH, Kim CY, Park K, Kim YI, Shin YS. (2003). Kor J Prev Med. 36(2): 1–26 (Korean).Google Scholar
  26. Marshall FF. (2002). J Urol. 168(2): 877.Google Scholar
  27. Ministry of Health and Welfare. (2001). National Health and Nutrition Survey 1998. Korea.Google Scholar
  28. Ministry of Health and Welfare. (2007). National Health and Nutrition Survey 2001. Korea.Google Scholar
  29. Murray CJ, Salomon JA, Mathers CD, Lopez AD. (2002). Summary Measures of Population Health: Concepts, Ethics, Measurement and Applications. WHO, Geneva.Google Scholar
  30. Murray CJL, Lauer JA, Hutubessy RCW, Niessen L, Tomijima N, Rodgers A, Laroes CM, Evans DB. (2003). Lancet. 361: 717–725.PubMedCrossRefGoogle Scholar
  31. Murray CJL, Lopez AD. (1996). The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Disease. Injuries and Risk Factors in 1990 and Projected to 2020. Harvard School of Public Health, WHO and World Bank, Boston.Google Scholar
  32. National Institute of Health. (2000). Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Available at http://www.nhlbi.nih.gov/guidelines/obesity/ob_home.htm.
  33. National Institutes of Health. (1998). Obes Res. 6: 51S–209S.Google Scholar
  34. National Task Force on the Prevention and Treatment of Obesity. (2000). Arch Int Med. 160: 898–904.Google Scholar
  35. Njolstad I, Arnesen E, Lund-Larsen PG. (1998). Am J Epidemiol. 147(1): 49–58.PubMedGoogle Scholar
  36. Norgan NG. (1994). Eur J Clin Nutr. 48(Suppl. 3): 10–25; discussion 26-27.Google Scholar
  37. O’Brien TE, Ray JG, Chan WS. (2003). Epidemiology. 14(3): 368–374.PubMedCrossRefGoogle Scholar
  38. Oh SW, Shin SA, Yun YH, Yoo T, Huh BY. (2004). Obes Res. 12(12): 2031–2040.PubMedCrossRefGoogle Scholar
  39. Park JH, Yoon SJ, Lee H, Jo HS, Kim Y, Kim YI and Shin Y. (2006). Int J Obes. 30: 1661–1669.CrossRefGoogle Scholar
  40. Reilly JJ, Methven E, McDowell ZC, Hacking B, Alexander D, Stewart L, Kelnar CJ. (2003 Sep). Arch Dis Child. 88(9): 748–752.PubMedCrossRefGoogle Scholar
  41. Rodgers A, Ezzati M, Vander Hoorn S, Lopez AD, Lin RB, Murray CJ. (2004). PLoS Med. 1(1): e27.PubMedCrossRefGoogle Scholar
  42. Rodgers A, Lawes C, MacMahon S. (2000). J Hypertens. 18: S3–S5.Google Scholar
  43. Rose G. (1992). The Strategy of Preventive Medicine. Oxford University Press, Oxford, 138 P.Google Scholar
  44. Strauss RS. (2000). Pediatrics. 105: e15.PubMedCrossRefGoogle Scholar
  45. Tai ES, Ho SC, Fok AC, Tan CE. (1999). Ann Acad Med Singapore. 28: 445–450.PubMedGoogle Scholar
  46. Van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, et al. (2000). Am J Epidemiol. 152(6): 514–527.PubMedCrossRefGoogle Scholar
  47. Victorian Burden of Disease Study. (1999). Morbidity. Victorian Government, Department of Human Services, Public Health and Development Division, Melbourne, Victoria.Google Scholar
  48. Visscher TL, Seidell JC. (2001). Annu Rev Public Health. 22: 355–375.PubMedCrossRefGoogle Scholar
  49. Walter SD. (1976). Biometrics. 32: 829–849.PubMedCrossRefGoogle Scholar
  50. Weintraub JM, Willett WC, Rosner B, Colditz GA, Seddon JM, Hankinson SE. (2002). Int J Obes Relat Metab Disord. 26(12): 1588–1595.PubMedCrossRefGoogle Scholar
  51. WHO. (2000). Obesity-Preventing and Managing the Global Epidemic. World Health Organization, Geneva.Google Scholar
  52. World Health Organization. (2002). The World Health Report 2002: Reducing Risks, Promoting Healthy Life. World Health Organization, Geneva, p. 250.Google Scholar
  53. Zhou BF. (2002). Biomed Environ Sci. 15(3): 245–252.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2010

Authors and Affiliations

  • Seok-Jun Yoon
  • Jae-Hyun Park

There are no affiliations available

Personalised recommendations